Predictors of Prescribing Atorvastatin 80mg in ACS
As shown in Table 5 , the likelihood of physicians prescribing atorvastatin 80mg increased by around four folds in patients diagnosed with STEMI (aOR= 3.8, 95% CI 2.2-6.5; P<0.001). The increase in tendency to prescribe atorvastatin 80mg was also observed in ACS patients who underwent PCI (aOR of 2.8, 95% CI 1.5-5.2; P=0.001). Similarly, the use of BMS was associated with around 2-fold increase in atorvastatin 80mg prescription (aOR= 2.2, 95% CI 1.1-4.3; P=0.024).